Prostate cancer gene mutation raises risk of death by threefold
A mutation that raises a prostate cancer patient's risk of death by threefold has been discovered...
Dr Charlott Repschlager is a Volunteer Writer at BioNews and works as a Medical Manager in Berlin. She has completed a PhD at King's College London Institute of Psychiatry, Psychology & Neuroscience. Previously, she has worked as a postdoctoral researcher in cancer at Queen Mary University of London and as a science communications officer. She has studied Human and Medical Science at the University of Westminster.
A mutation that raises a prostate cancer patient's risk of death by threefold has been discovered...
A pilot study on a breath test to detect cancer has been launched in the UK...
Australian researchers have developed a cancer test, which could potentially detect cancerous DNA in blood and tissue samples in under 10 minutes...
Researchers have successfully used genome editing in mice to correct a genetic mutation that causes the liver disease phenylketonuria (PKU)...
Almost a quarter of all cancer gene test variations were amended due to reclassification over the course of a decade, found a new study...
Four organ recipients developed cancer after doctors did not detect breast cancer in an organ donor...
Dogs with Duchenne muscular dystrophy (DMD) have been treated using genome editing, a study in Science reports...
Pre-implantation genetic testing of embryos does not improve IVF birth rates in older women, found the largest study of its kind yet...
Assisted reproduction techniques such as IVF do not increase a woman's risk of developing womb or breast cancer, a new study has found...
The latest event organised by the Progress Educational Trust, 'With great genomic data comes great responsibility', came at a perfect time...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.